- US12606603utility2026IL-13 Receptor Alpha 2 Targeted, Zetakine Directed T Cell Immunotherapy0 cites
- US12595492utility2026Rapamycin Resistant Cells0 cites
- US12570716utility2026Anti-dinitrophenol Chimeric Antigen Receptors0 cites
- US12509661utility2025Compositions and Methods Related to Aptamer-based Reversible Cell Selection0 cites
- US12503507utility2025Defined Composition Gene Modified T-cell Products0 cites
- US12466885utility2025Bispecific Chimeric Antigen Receptors and Encoding Polynucleotides, Vectors and Cells Thereof0 cites
- US12467064utility2025Artificial Expression Constructs for Selectively Modulating Gene Expression in Interneurons0 cites
- US12448445utility2025Transgene Genetic Tags and Methods of Use0 cites
- US12433960utility2025Vivo Gene Therapy Using Intraosseous Delivery of a Lentiviralgene Construct0 cites
- US12312416utility2025Fluorescein-specific Cars Exhibiting Optimal T Cell Function Against FL-PLE Labelled Tumors0 cites
- US12269862utility2025Methods of Use for CAR T Cells0 cites
- US12240870utility2025Sequencing Method for CAR T Cell Therapy0 cites
- US12233090utility2025Bispecific Or-gate Chimeric Antigen Receptor Responsive to CD20 and CD190 cites
- US12226435utility2025Bispecific Or-gate Chimeric Antigen Receptor Responsive to CD20 and CD190 cites
- US12214026utility2025Vaccine for Falciparum Malaria0 cites
- US12215324utility2025Monocyte and Macrophage Binding Aptamers and Their Application0 cites
- US12202897utility2025Drug Regulated Transgene Expression0 cites
- US12180457utility2024Closed-system Manufacturing Process for CAR-T Cells0 cites
- US12173071utility2024Methods and Compositions Comprising B7H3 Chimeric Antigen Receptors0 cites
Page 1 of 3Next →